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CNS microRNA profiles: a database
for cell type enriched microRNA
expression across the mouse
central nervous system
Nathan Pomper 1,2,5, Yating Liu3,5, Mariah L. Hoye2, Joseph D. Dougherty3,4* &
Timothy M. Miller2*
microRNAs are short, noncoding RNAs that can regulate hundreds of targets and thus shape the
expression landscape of a cell. Similar to mRNA, they often exhibit cell type enriched expression and
serve to reinforce cellular identity. In tissue with high cellular complexity, such as the central nervous
system (CNS), it is difficult to attribute microRNA changes to a particular cell type. To facilitate
interpretation of microRNA studies in these tissues, we used previously generated data to develop a
publicly accessible and user-friendly database to enable exploration of cell type enriched microRNA
expression. We provide illustrations of how this database can be utilized as a reference as well as
for hypothesis generation. First, we suggest a putative role for miR-21 in the microglial spinal injury
response. Second, we highlight data indicating that differential microRNA expression, specifically
miR-326, may in part explain regional differences in inflammatory cells. Finally, we show that miR-383
expression is enriched in cortical glutamatergic neurons, suggesting a unique role in these cells. These
examples illustrate the database’s utility in guiding research towards unstudied regulators in the CNS.
This novel resource will aid future research into microRNA-based regulatory mechanisms responsible
for cellular phenotypes within the CNS.
microRNAs (miRNAs) are short, regulatory RNA molecules that become functionally active after being incorporated into the RNA-induced silencing complex (RISC), containing Argonaute-21,2. Canonically, miRNA bind
target mRNA in their 3′ untranslated region via Watson-Crick base pairing to regulate translation by either direct
translational inhibition or mRNA destabilization3. Because only partial complementarity is required for a miRNA
to regulate mRNA translation, miRNAs can regulate hundreds of transcripts in a given cell type4. This widespread
regulation enables miRNAs to profoundly shape the expression landscape and physiology of a cell. Similar to transcription factors, the cell type specific miRNA code can tune which genes are actively expressed in a given cell type5.
In fact, several groups have demonstrated that ectopic miRNA expression is sufficient to direct and reprogram cell
identity, including induced pluripotent stem cells and neurons6,7. It is therefore important to know which miRNAs
are expressed in a given cell type, but this is difficult in a complex tissue such as the central nervous system (CNS).
Previous studies have performed miRNA-ome analyses of the CNS. For example, Bak and colleagues undertook a large scale analysis of miRNA expression across 13 distinct neuroanatomical regions, but lacked the resolution to describe miRNA expression on a cell type specific basis within these nervous system tissues8. To enable cell
type specific resolution analysis of miRNA expression, He et al. developed a tool for genetic expression of a tagged
Argonaute-2 in mice, characterizing miRNA expression in several neuronal cell types in cortex and cerebellum9.
However, the field remains hindered by a lack of a thorough cell type specific analysis of miRNA expression across
the CNS. Additionally, there has yet to be a publicly accessible and user-friendly database describing cell type
specific miRNA expression within the nervous system.
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Figure 1. ‘Search by miRNA’ output for miR-21. Expression is consistently enriched in microglial/immune cells
within nervous system tissues under physiological conditions (n = 3–4 mice; mean ± SEM). The “Claret” colored
frame indicates that miR-21a-5p is broadly conserved among most vertebrate, usually including zebrafish.

To solve this second problem, we pooled data across studies utilizing this Cre-dependent miRNA affinity
purification technique9 to identify cell type specific miRNAs across major cell types within the mouse CNS. In
addition to the He study, we previously leveraged this affinity purification technique to identify miRNAs known
to be important for particular cell types, such as the motor neuron-enriched miR-21810–12. This discovery enabled
further study of how aberrant miR-218 expression in cell types that do not physiologically express miR-218, such
as astrocytes, mediates their dysfunction in a disease like amyotrophic lateral sclerosis13. This example illustrates
how identifying cell type specific expression of even a single microRNA can be the starting point for a productive
line of experimental investigation.
In this report, we describe the creation of a website (miRNA.wustl.edu) to provide a platform for comparing miRNA expression for various cell types within nervous system tissue using data generated in Hoye et al.,
201714 and He et al., 20129. Similar sources for protein-coding RNA, including the Brain RNA-Seq atlas14, have
become widespread research tools in considering which cell types may be involved in an observed phenotype15. Our resource will assist future hypothesis generation and experimental analyses by informing on specific
miRNA-mediated regulatory mechanisms in particular nervous system cell types.

Results

We developed the database to allow interactions with the datasets in two ways – a ‘Search by miRNA’ function that
will provide graphic illustration for expression of a given miRNA and related family members, and a ‘Search by
Cell Type’ function that will allow the end user to conduct a variety of differential expression contrasts to identify
miRNAs that may be enriched in a cell type of interest in an unbiased way. Below, we provide several vignettes
demonstrating the utility of these functions.

‘Search by miRNA’ highlights the potential role of microglial miR-21a-5p in spinal cord injury.

One common use for databases is to identify cell types of interest in a given phenotype. As a proof of principle, we
leveraged our database to help generate a novel hypothesis regarding a previously undescribed role for microglial
miRNA in spinal cord injury. Several groups have identified miR-21 as significantly upregulated after spinal cord
injury, causing downregulation of targets FasL and PTEN, and its expression is directly related to secondary cell
death following injury16–18. By in situ hybridization, miR-21 was expressed in neurons after injury but the majority
of its expression seems to occur in other cell types18. One study demonstrated miR-21 expression in astrocytes
following injury both promoted glial scar formation and hindered axonal regrowth, underscoring the importance
of cell types beyond neurons in the miR-21 injury response19. Our database confirms the expression of miR-21 in
spinal astrocytes but also indicates an even greater expression in spinal microglia, that is consistent with brainstem expression (Fig. 1). Therefore, for those interested in the importance of miR-21 after spinal cord injury, our
database emphasizes that microglia likely play an underappreciated role. Consistent with this, some evidence
directly points to the neurotoxic effect of microglial FasL and its repression by microglial miR-2120, but this has
yet to be investigated in the context of spinal cord injury.

‘Search by miRNA’ reveals cell level regional variability in miR-326-3p expression.

An additional use for our database is to compare regional expression of miRNAs, highlighting potential differences in
development and physiology of cells within distinct locations. miR-326 is an extreme example of a potentially
important regional difference. Our database identifies miR-326 as an almost exclusively microglial miRNA within
the brainstem, however miR-326 is largely absent from spinal microglia. Within the spine, miR-326 expression
is largely restricted to astrocytes (Fig. 2A). miR-326 has been implicated as a pro-inflammatory miRNA in circulating CD4+ T cells21, so this distinction may contribute to differences in immune and inflammatory responses
within these neuroanatomically distinct structures. For example, in response to a common peroneal nerve injury,
microglia are activated within the spine, but not the medulla22. Regional differences, such as those in miR-326
expression, could underlie this differential response. Interestingly, this regional difference is further complicated
by extension to other nervous system regions. For example, miR-326 is enriched in the cerebellum over Purkinje
neurons, consistent with previous findings that glial cells express substantially more miR-326 than neurons
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Figure 2. (A) ‘Search by miRNA’ output for miR-326-3p in the brainstem and spinal cord. Expression is readily
detectable exclusively in microglia of the brainstem and astrocytes of the spine (n = 3–4 mice; mean ± SEM).
(B) ‘Search by miRNA’ output for miR-326-3p in the cerebellum. miR-326-3p is depleted in Purkinje neurons,
relative to the cerebellum as a whole (n = 2–3 mice; mean ± SEM). (C) ‘Search by miRNA’ output for miR326-3p in the neocortex. miR-326-3p is readily detectable in cortical neurons (n = 2–3 mice; mean ± SEM).
Only the more predominant and conserved 3p strand is displayed. The “Valencia” colored frame indicates that
miR-326-3p is conserved among most mammals.

(Fig. 2B). However, unlike other assayed regions, miR-326 is readily detectable in neocortical neurons, particularly interneuron subtypes (Fig. 2C). This indicates further regional variability, where miR-326 is expressed
by more rostral neurons despite the lack of substantial neuronal expression in the brainstem, spinal cord and
cerebellum.

miR-383-5p expression highlights a potential specific regulatory role in glutamatergic neurons
in the cortex. Having two datasets included in our resource can provide complementary information. While

Hoye et al. 2017 informs on neurons compared to glia, He et al. 2012 supplies information on neuronal subtypes.
This is particularly informative in the case of a miRNA that is enriched in neurons over glia, but its neuronal
subtype enrichment is less clear. miR-383-5p is an example of one such neuronal miRNA. In both the brainstem
and spinal cord, miR-383 is enriched in all neurons, as well as motor neurons, compared to glial cells (Fig. 3A).
miR-383 expression is similarly enriched in Purkinje neurons over the cerebellum as a whole, but this does not
aid in identifying the particular neuronal subtypes that are responsible for the majority of miR-383 expression
(Fig. 3B). However, the neocortical dataset reveals that miR-383 is not equally distributed across neuronal subtypes. miR-383 is particularly expressed by CamKIIa-positive glutamatergic neurons, relative to other neuronal
subtypes (Fig. 3C). Interestingly, the expression of miR-383 has been tied to several neurodevelopmental and
neuropsychiatric conditions. This includes Rett syndrome23, fragile X syndrome24, bipolar disorder25 and schizophrenia26. Further genomic-level analyses have revealed that the miR-383 locus and target genes are associated with an increased risk for autism spectrum disorder and linked behaviors, such as rumination27,28. These
studies suggest that alterations in miR-383 levels and its corresponding targets may be detrimental to maintaining the proper function of neurons, particularly excitatory cortical neurons. It is also possible that miR-383 is
mis-expressed by other neuronal subtypes. If supported by future experimental studies, such aberrant miR-383
expression could contribute to excitation-inhibition imbalance often associated with neurodevelopmental and
psychiatric conditions.

‘Search by cell type’ identifies potential novel modulators of spinal motor neuron and immune
cell function. We provide end-users with the functionality to search miRNA enrichment by cell type. This

feature enables identification of the most abundant and/or most specifically expressed miRNA within a given
cell type. For example, Fig. 4A details the top spinal motor neuron miRNA, relative to all other cell types assayed
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Figure 3. (A) ‘Search by miRNA’ output for miR-383-5p in the spine and brainstem. Expression is consistently
and statistically enriched in neuronal cells over glia (n = 3–4 mice; mean ± SEM). (B) ‘Search by miRNA’ output
for miR-383-5p in the cerebellum. Expression is enriched in Purkinje neurons, relative to the cerebellum as a
whole (n = 2–3 mice; mean ± SEM). (C) ‘Search by miRNA’ output for miR-383-5p in the neocortex. Expression
is highly expressed across neuronal subtypes but is most highly expressed by CamKIIa-positive glutamatergic
neurons (n = 2–3 mice; mean ± SEM). Only the more predominant and conserved 5p strand is displayed. The
“Claret” colored frame indicates that miR-383-5p is broadly conserved among most vertebrates.

(including pan-neuronal miRNAs). This identifies both miR-218 strands, as well as potentially novel modulators
of motor neuron function, including miR-544-3p. The loss of motor neuron-enriched miR-544 in whole spinal
cord lysates has been associated with insults in the form of spinal cord injury29 or amyotrophic lateral sclerosis
mutation-carrying muscle30, indicating a novel regulatory mechanism underlying motor neuron homeostasis.
Additionally, Fig. 4B highlights the top 10 enriched miRNAs in spinal microglia as compared to all spinal neurons. This analysis yields miRNAs known to be associated with immune responses, including miR-223-3p31,
but also novel miRNAs that have not been previously associated with microglial function. Overall, there were a
number of miRNAs that were significantly expressed above background and relatively enriched in each cell type
and CNS region (Table 1).

Discussion

In this report, we detail the creation of a publicly accessible and user-friendly website for analyzing cell type
enriched microRNA expression and demonstrate its utility to several distinct biological scenarios.
The dual ‘Search by miRNA’ and ‘Search by cell type’ functionality will enable end-users to quickly determine
which neural cells may be associated with a given miRNA-associated phenotype they might observe throughout
the course of their study. For example, we leveraged our database to identify microglia-enriched miR-21 regulation of FasL as a likely modulator to secondary neuron injury in spinal cord injury models. It can be equally
informative to know which miRNAs are not expressed by a given physiological cell type. For example, the fact
that adult astrocytes do not express miR-218, supports the hypothesis that motor neuron-derived miR-218 may
contribute to the loss of astrocytic EAAT2 seen in amyotrophic lateral sclerosis13. Understanding which cell types
express a particular miRNA may also guide development of inhibitors for miRNA, for example miR-155 in amyotrophic lateral sclerosis32,33.
One limitation of our database is that the data were produced under physiological conditions in healthy, adult
mice. It will be important to incorporate additional information into the database based on cell type specific
miRNA expression under a variety of conditions, such as across multiple developmental time points. Additionally,
we recognize that a more comprehensive miRNA analysis of other cell types in the neocortex and cerebellum, as
well as a deeper analysis of the brainstem and spinal cord samples, for example by small RNA sequencing, would
provide additional information. The use of this sequencing technology indeed produced a greater number of
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Figure 4. (A) Top 10 miRNAs of spinal motor neurons compared to all other cell types. miRNAs were selected
and sorted by pSI value. (B) Top 10 microglial miRNAs as compared to all neurons in the spine, sorted by
Log2FC.

All neurons

Brainstem

Spinal Cord Neocortex

Cerebellum

19

21

—

—

Motor neurons

52

60

—

—

Astrocytes

54

63

—

—

Microglia

59

57

—

—

Interneurons

—

—

102

—

Glutamatergic neurons —

—

90

—

PV + interneurons

—

115

—

—

SOM + interneurons

—

—

152

—

Purkinje neurons

—

—

—

155

Table 1. Number of detectable miRNAs statistically enriched in each assayed population relative to tissue level
expression.

enriched miRNAs per cell type in the He data over the microarray approach utilized by the Hoye data, perhaps
due to the increased sensitivity to detect less abundant miRNA.
The database is set up such that it can easily accommodate the incorporation of additional cell-specific miRNA
information. While the database is presently limited to the central nervous system, this strategy can be applied to
any tissue with characterized Cre driver lines. For example, we have previously utilized this miRNA-tagging and
affinity purification technique to characterize differences between CD11c+ dendritic cells of the spleen and CNS
infiltrates during experimental autoimmune encephalitis34.
Existing miRNA tools are useful for target prediction, but fail to provide context as to whether a given
miRNA and its putative target mRNA are co-expressed in the same cell type. By pairing this database with current resources for mRNA expression, future studies can uncover novel cell type specific gene regulatory patterns
and if these patterns are pathologically disrupted. This database adds to the existing body of resources available
for studying miRNAs, including target prediction software and broadens the wealth of information available to
researchers studying miRNA regulation.

Methods

Animals. More details concerning the animals used in the generation of this database can be found in Hoye
et al. 201710 and He et al. 20129. For Hoye et al. 2017, tissue was harvested from n = 3–4 per group at P63. For
He et al. 2012, tissue was harvested from n = 2–3 animals per group at P56. All animals were maintained on a
C57BL/6 background. The following Cre lines were crossed to the loxP-STOP-loxP-GFP-myc-Ago2 line: Syn (all
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neurons), ChAT (motor neurons), GFAP (astrocytes), Lyz2 (microglia), Gad2 (interneurons), CamKIIa (glutamatergic neurons), Pv (parvalbumin-positive interneurons), SST (somatostatin-positive interneurons) and L7
(Purkinje neurons of the cerebellum).

Data collection and analysis. The data used to generate this online database were taken from Hoye et al.
201710 and He et al. 20129, where a more detailed description of the data generation method can be found. Briefly,
cell type specific miRNAs within the mouse brainstem (pons and medulla), whole spinal cord, neocortex and
cerebellum were identified using a Cre-dependent miRNA affinity purification technique using cell type specific
expression of a GFP-tagged Ago2, followed by anti-myc capture. In Hoye et al. 2017, the bound miRNA samples
were analyzed by microarray. Ct (cycle threshold) counts were LoessM normalized35 for each as a measure of the
miRNA expression in each cell type. In He et al. 2012, the bound miRNA samples were analyzed by small RNA
sequencing. The resulting counts, renormalized to library size (as counts per million – CPM) were used here. For
each tissue, an Ago2 affinity purification was performed to obtain a tissue-wide miRNA profile. In Hoye et al.
2017, identical myc immunoprecipitation experiments were performed in non-transgenic animals to determine
background miRNA expression associated with the immunoprecipitation. The relative expression data, log2 fold
changes between any two given cell types and the associated adjusted p-values, were generated for all pairwise
comparisons between cell types in each tissue. The specificity index (pSI) value for each miRNA in each cell type is
used to define its enrichment in the corresponding cell type as compared to all other cell types and total tissue36. pSI
cutoffs can be varied to define very stringent enrichment (e.g. 10E-5), or moderate enrichment (<0.05). A miRNA
was considered detectable in the brainstem and spinal cord if its average Ct ≤ 35 and if 2 of 3 biological replicates
exceeded the median background Ct. For the neocortex and cerebellum, where immunoprecipitation background
data was not available, a miRNA was considered detectable if its CPM ≥ 1 in at least two biological replicates.
Database creation. The CNS microRNA profiles website was built with Django framework version 1.11
(https://www.djangoproject.com/weblog/2009/), using Python 3.6, SQLite database, and is deployed using mod_
wsgi-express (https://github.com/GrahamDumpleton/mod_wsgi).
Search by miRNA. The ‘Search by miRNA’ functionality allows a user to visualize the relative expression of a

miRNA in the cell types within the brainstem, spinal cord, neocortex and cerebellum. Upon entering a miRNA
name, the webpage will display a list of expression bar plots for the query miRNA and other miRNAs belonging to
the same group. The top color frame contains the expression plots of the query miRNA in the available tissues. If the
miRNA is not available in neocortex and cerebellum, the color frame will only contains its expression plots in
brainstem and spinal cord, and vice versa. The expression plots in brainstem and spinal cord show the relative fold
changes of the query miRNA in four cell types in brainstem and spinal cord, respectively. Within each bar graph,
miRNA expression is normalized to all neurons (baseline = mean Ct of all neurons), the relative fold change of
which is set to 1.0. All other cell types are displayed as expression relative to all neurons (2baseline −mean Ct ). Mean Ct
of each cell type, as a more direct measure of abundance, is shown beneath the cell type names on the x-axis. For
RNAseq-based data, the y-axis instead represents log CPM. A second y-axis was added on the right side with the
corresponding non-log CPM values shown. The error bars show the standard error of the mean. If the miRNA is
not detectable in a cell type, an “ND” marker in red will be displayed. As the data for this database was generated in
mice, we included conservation information for potential extension to human systems and because the more conserved miRNA are likely to be more predominantly expressed. This information is conveyed on the webpage via a
colored frame around the miRNA of interest that represents its level of conservation. The conservation data was
drawn from the TargetScan37 “miR Family” data table (http://www.targetscan.org/mmu_72/mmu_72_data_download/miR_Family_Info.txt.zip). Any figure can be downloaded as PDF or PNG images for use with attribution.

Search by cell type. The ‘Search by cell type’ functionality allows a user to find miRNAs that are enriched in

one cell type (cell type 1) compared to another cell type or all other cell types (cell type 2), in any one of the four
tissues: brainstem, spinal cord, neocortex and cerebellum. After specifying the tissue type, cell type 1, cell type
2, sorting method, and number of top enriched miRNAs, the webpage will display a data table showing the top
enriched miRNAs in cell type 1 relative to cell type 2, and its corresponding Ct / CPM value in each cell type. The
miRNAs will be sorted by log2 fold change in descending order or p-value in ascending order, if directly comparing two cell types. The miRNAs will be sorted by pSI in ascending order, if comparing one cell type to all other cell
types. The results table can be downloaded as a CSV data file, PDF, or Excel spreadsheet.

Data availability

An Excel spreadsheet containing the raw data from each dataset can be downloaded from the “Download Data”
page on the website.
Received: 29 July 2019; Accepted: 24 February 2020;
Published: xx xx xxxx
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